Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Tumor Cell Invasion Induced by Radiation in Balb/C Mouse is Prevented by the Cox-2 Inhibitor NS-398.

Lemay R, Lepage M, Tremblay L, Therriault H, Charest G, Paquette B.

Radiat Res. 2017 Dec;188(6):605-614. doi: 10.1667/RR14716.1. Epub 2017 Sep 28.

PMID:
28956695
2.

Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

Wilcox WR, Feldt-Rasmussen U, Martins AM, Ortiz A, Lemay RM, Jovanovic A, Germain DP, Varas C, Nicholls K, Weidemann F, Hopkin RJ.

JIMD Rep. 2018;38:45-51. doi: 10.1007/8904_2017_28. Epub 2017 May 17.

3.

Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.

Hopkin RJ, Cabrera G, Charrow J, Lemay R, Martins AM, Mauer M, Ortiz A, Patel MR, Sims K, Waldek S, Warnock DG, Wilcox WR.

Mol Genet Metab. 2016 Sep;119(1-2):151-9. doi: 10.1016/j.ymgme.2016.06.007. Epub 2016 Jun 13.

4.

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.

Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR.

J Med Genet. 2015 May;52(5):353-8. doi: 10.1136/jmedgenet-2014-102797. Epub 2015 Mar 20.

5.

Fabry disease in latin america: data from the fabry registry.

Villalobos J, Politei JM, Martins AM, Cabrera G, Amartino H, Lemay R, Ospina S, Ordoñez SS, Varas C.

JIMD Rep. 2013;8:91-9. doi: 10.1007/8904_2012_165. Epub 2012 Jul 6.

6.

Cancer radiotherapy based on femtosecond IR laser-beam filamentation yielding ultra-high dose rates and zero entrance dose.

Meesat R, Belmouaddine H, Allard JF, Tanguay-Renaud C, Lemay R, Brastaviceanu T, Tremblay L, Paquette B, Wagner JR, Jay-Gerin JP, Lepage M, Huels MA, Houde D.

Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):E2508-13. Epub 2012 Aug 27.

7.

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.

Warnock DG, Ortiz A, Mauer M, Linthorst GE, Oliveira JP, Serra AL, Maródi L, Mignani R, Vujkovac B, Beitner-Johnson D, Lemay R, Cole JA, Svarstad E, Waldek S, Germain DP, Wanner C; Fabry Registry.

Nephrol Dial Transplant. 2012 Mar;27(3):1042-9. doi: 10.1093/ndt/gfr420. Epub 2011 Jul 29.

8.

Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells.

Lemay R, Archambault M, Tremblay L, Bujold R, Lepage M, Paquette B.

Int J Radiat Biol. 2011 May;87(5):472-82. doi: 10.3109/09553002.2011.542541. Epub 2011 Jan 13.

PMID:
21231833
9.

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

Wanner C, Oliveira JP, Ortiz A, Mauer M, Germain DP, Linthorst GE, Serra AL, Maródi L, Mignani R, Cianciaruso B, Vujkovac B, Lemay R, Beitner-Johnson D, Waldek S, Warnock DG.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2220-8. doi: 10.2215/CJN.04340510. Epub 2010 Sep 2.

10.

Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.

Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P.

Genet Med. 2009 Nov;11(11):790-6. doi: 10.1097/GIM.0b013e3181bb05bb.

PMID:
19745746
11.

A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.

Kishnani PS, DiRocco M, Kaplan P, Mehta A, Pastores GM, Smith SE, Puga AC, Lemay RM, Weinreb NJ.

Mol Genet Metab. 2009 Apr;96(4):164-70. doi: 10.1016/j.ymgme.2008.12.015. Epub 2009 Feb 4.

PMID:
19195916
12.

Using technology to improve patient collections.

Newland K, LeMay R.

Revenue-cycle Strateg. 2008 Dec;5(12):4-5. No abstract available.

PMID:
19127660
13.

Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.

Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR.

Pediatr Res. 2008 Nov;64(5):550-5. doi: 10.1203/PDR.0b013e318183f132.

PMID:
18596579
14.

Syndromic surveillance for influenzalike illness.

Lemay R, Mawudeku A, Shi Y, Ruben M, Achonu C.

Biosecur Bioterror. 2008 Jun;6(2):161-70. doi: 10.1089/bsp.2007.0056.

PMID:
18563993
15.

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP; Fabry Registry.

Mol Genet Metab. 2008 Feb;93(2):112-28. Epub 2007 Nov 26.

PMID:
18037317
16.

In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.

Paquette B, Baptiste C, Therriault H, Arguin G, Plouffe B, Lemay R.

Br J Cancer. 2007 Dec 3;97(11):1505-12. Epub 2007 Nov 6.

17.
18.

The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients.

Mangin L, Bertrand OF, De La Rochellière R, Proulx G, Lemay R, Barbeau G, Gleeton O, Rodés-Cabau J, Nguyen CM, Roy L.

J Invasive Cardiol. 2005 Feb;17(2):77-9.

PMID:
15687529
19.

Invasiveness of breast cancer cells MDA-MB-231 through extracellular matrix is increased by the estradiol metabolite 4-hydroxyestradiol.

Paquette B, Bisson M, Baptiste C, Therriault H, Lemay R, Cantin AM.

Int J Cancer. 2005 Feb 20;113(5):706-11.

20.

Dosimetry of ultrasoft x-rays (1.5 keV Al(Kalpha)) using radiochromatic films and colour scanners.

Cai Z, Pan X, Hunting D, Cloutier P, Lemay R, Sanche L.

Phys Med Biol. 2003 Dec 21;48(24):4111-24.

PMID:
14727755
21.

Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol.

Paquette B, Bisson M, Therriault H, Lemay R, Paré M, Banville P, Cantin AM.

J Steroid Biochem Mol Biol. 2003 Oct;87(1):65-73.

PMID:
14630092
22.

Time-dependent antibacterial effects of linezolid in experimental rabbit endocarditis.

Buchanan LV, Dailey CF, LeMay RJ, Zielinski RJ, Kuo MS, Gibson JK.

J Antimicrob Chemother. 2002 Sep;50(3):440-2. No abstract available.

PMID:
12205079
23.

In vitro pro- and antioxidant properties of estrogens.

Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day BJ, Paquette B.

J Steroid Biochem Mol Biol. 2002 Jul;81(3):227-36.

PMID:
12163134
24.

In vitro generation of peroxynitrite by 2- and 4-hydroxyestrogens in the presence of nitric oxide.

Paquette B, Cantin AM, Kocsis-Bédard S, Barry S, Lemay R, Jay-Gerin JP.

Chem Res Toxicol. 2001 May;14(5):547-54.

PMID:
11368553
25.

Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential.

Hester JB, Gibson JK, Buchanan LV, Cimini MG, Clark MA, Emmert DE, Glavanovich MA, Imbordino RJ, LeMay RJ, McMillan MW, Perricone SC, Squires DM, Walters RR.

J Med Chem. 2001 Mar 29;44(7):1099-115.

PMID:
11297456
26.

The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.

Althaus IW, Chou KC, Lemay RJ, Franks KM, Deibel MR, Kezdy FJ, Resnick L, Busso ME, So AG, Downey KM, Romero DL, Thomas RC, Aristoff PA, Tarpley WG, Reusser F.

Biochem Pharmacol. 1996 Mar 22;51(6):743-50.

PMID:
8602869
27.

Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.

Buchanan LV, LeMay RJ, Walters RR, Hsu CY, Brunden MN, Gibson JK.

J Cardiovasc Electrophysiol. 1996 Feb;7(2):113-9.

PMID:
8853021
28.

Seedling growth and development on space shuttle.

Cowles J, LeMay R, Jahns G.

Adv Space Res. 1994 Nov;14(11):3-12.

PMID:
11540197
29.

Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor.

Althaus IW, Chou JJ, Gonzales AJ, LeMay RJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Thomas RC, Aristoff PA, et al.

Experientia. 1994 Jan 15;50(1):23-8.

30.

Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.

Althaus IW, LeMay RJ, Gonzales AJ, Deibel MR, Sharma SK, Kezdy FJ, Resnick L, Busso ME, Aristoff PA, Reusser F.

Experientia. 1992 Dec 1;48(11-12):1127-32.

PMID:
1282106
31.

Maîtres apothicaires et limitation des officines à Lunéville en 1770.

Lemay R.

Rev Hist Pharm (Paris). 1989;36(280):14-26. French. No abstract available.

PMID:
11637916
32.

Microgravity effects on plant growth and lignification.

Cowles JR, Lemay R, Jahns G.

Astrophys Lett Commun. 1988;27:223-8.

PMID:
11539286
33.

[Iatronic section of the spinal nerve in cervical lymph node biopsies].

Arjane G, Lemay R, Guay JP.

Union Med Can. 1985 Apr;114(4):319-22, 329. French. No abstract available.

PMID:
4012902
34.

Growth and development of plants flown on the STS-3 Space Shuttle mission.

Cowles JR, Scheld HW, Peterson C, LeMay R.

Acta Astronaut. 1984 May;11(5):275-7.

PMID:
11541789
35.

Growth and lignification in seedlings exposed to eight days of microgravity.

Cowles JR, Scheld HW, Lemay R, Peterson C.

Ann Bot. 1984;54(Suppl 3):33-48.

PMID:
11539752
36.

[Electromyography in the differential diagnosis of infant hypotonia].

Vanasse M, Lemay R, Brochu P.

Union Med Can. 1982 Apr;111(4):347-51, 397. French. No abstract available.

PMID:
6283702
37.

The teaching of astronomy in medieval universities, principally at Paris in the forteenth century.

Lemay R.

Manuscripta. 1976 Nov;20(3):197-217. No abstract available.

PMID:
11614894
38.

Attitudes of nurses, physicians and pharmacists toward a unit dose drug distribution system.

Simon JR, Tester WW, LeMay RP.

Am J Hosp Pharm. 1968 May;25(5):239-47. No abstract available.

PMID:
5742823
39.

Tape recorder collects work study data.

LeMay RP, Ashour S.

Mod Hosp. 1966 Sep;107(3):68-70. No abstract available.

PMID:
5947464
40.

[New alkaloids of Vinca major L. (Apocynaceae): alkaloids of the periwinkle. 32].

Plat M, Lemay R, Le Men J, Janot MM, Djerassi C, Budzikiewicz H.

Bull Soc Chim Fr. 1965 Sep;9:2497-501. French. No abstract available.

PMID:
5848683
41.

[NEW LEGISLATION ON TRADE MARKS, COMMERCE MARKS OR SERVICE MARKS].

DILLEMANN G, LEMAY R.

Prod Probl Pharm. 1965 Feb;20:92-6. French. No abstract available.

PMID:
14307807

Supplemental Content

Support Center